Fortis Healthcare Limited has announced that a meeting of its Board of Directors is scheduled for May 22, 2026. The primary agenda involves the consideration and approval of the company’s audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. Furthermore, the board will deliberate on the recommendation of a final dividend for the equity shareholders for the same financial period.
Financial Results and Dividend Review
Fortis Healthcare is set to review its financial performance for the quarter and full financial year concluding on March 31, 2026. During this upcoming meeting, the Board of Directors will evaluate the audited financial statements on both a standalone and consolidated basis. Additionally, the leadership team will assess the possibility of declaring a final dividend for equity shareholders, reflecting the company’s financial health for the fiscal year.
Trading Window Restrictions
In accordance with corporate governance protocols, the company has confirmed that the trading window for dealing in its securities remains closed. This restriction began previously and will continue until 48 hours after the official declaration of the audited financial results. Accordingly, the trading window is expected to reopen on May 24, 2026, following the conclusion of the board’s review.
Source: BSE
